DEF 14A

Company

Cue Biopharma, Inc.

Filed

March 16, 2026

Period of Report

March 16, 2026

Accession Number

0001193125-26-108301

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →